Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. vs ADVANCED ENZYME TECHNOLOGIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENNEX LAB. ADVANCED ENZYME TECHNOLOGIES GENNEX LAB./
ADVANCED ENZYME TECHNOLOGIES
 
P/E (TTM) x 35.0 27.9 125.2% View Chart
P/BV x 4.5 3.1 143.1% View Chart
Dividend Yield % 0.0 1.4 -  

Financials

 GENNEX LAB.   ADVANCED ENZYME TECHNOLOGIES
EQUITY SHARE DATA
    GENNEX LAB.
Mar-23
ADVANCED ENZYME TECHNOLOGIES
Mar-23
GENNEX LAB./
ADVANCED ENZYME TECHNOLOGIES
5-Yr Chart
Click to enlarge
High Rs9328 2.8%   
Low Rs5225 2.1%   
Sales per share (Unadj.) Rs3.448.3 6.9%  
Earnings per share (Unadj.) Rs0.39.3 3.0%  
Cash flow per share (Unadj.) Rs0.312.4 2.7%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Avg Dividend yield %01.8 0.0%  
Book value per share (Unadj.) Rs4.5110.5 4.1%  
Shares outstanding (eoy) m176.64111.82 158.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.15.7 36.2%   
Avg P/E ratio x25.029.8 83.8%  
P/CF ratio (eoy) x21.022.3 94.4%  
Price / Book Value ratio x1.52.5 61.0%  
Dividend payout %053.8 0.0%   
Avg Mkt Cap Rs m1,22930,939 4.0%   
No. of employees `000NANA-   
Total wages/salary Rs m791,148 6.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5935,406 11.0%  
Other income Rs m40255 15.5%   
Total revenues Rs m6335,661 11.2%   
Gross profit Rs m471,534 3.1%  
Depreciation Rs m9350 2.6%   
Interest Rs m1435 38.9%   
Profit before tax Rs m641,404 4.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15365 4.0%   
Profit after tax Rs m491,039 4.7%  
Gross profit margin %7.928.4 27.9%  
Effective tax rate %22.826.0 87.6%   
Net profit margin %8.319.2 43.2%  
BALANCE SHEET DATA
Current assets Rs m4877,221 6.7%   
Current liabilities Rs m295776 38.0%   
Net working cap to sales %32.3119.2 27.1%  
Current ratio x1.69.3 17.7%  
Inventory Days Days4255 1.6%  
Debtors Days Days57,912,58968 85,488,451.9%  
Net fixed assets Rs m8356,884 12.1%   
Share capital Rs m180224 80.6%   
"Free" reserves Rs m62312,127 5.1%   
Net worth Rs m80412,351 6.5%   
Long term debt Rs m16378 208.8%   
Total assets Rs m1,32214,105 9.4%  
Interest coverage x5.741.4 13.8%   
Debt to equity ratio x0.20 3,210.2%  
Sales to assets ratio x0.40.4 117.1%   
Return on assets %4.77.6 62.4%  
Return on equity %6.18.4 72.8%  
Return on capital %8.011.6 69.1%  
Exports to sales %42.117.3 243.1%   
Imports to sales %13.67.8 174.9%   
Exports (fob) Rs m250937 26.7%   
Imports (cif) Rs m81420 19.2%   
Fx inflow Rs m250937 26.7%   
Fx outflow Rs m86420 20.6%   
Net fx Rs m164518 31.7%   
CASH FLOW
From Operations Rs m2371,404 16.9%  
From Investments Rs m-383-2,982 12.9%  
From Financial Activity Rs m210-258 -81.5%  
Net Cashflow Rs m64-1,709 -3.7%  

Share Holding

Indian Promoters % 23.6 2.6 925.5%  
Foreign collaborators % 0.0 41.1 -  
Indian inst/Mut Fund % 0.0 29.5 -  
FIIs % 0.0 22.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 76.4 56.4 135.5%  
Shareholders   69,723 73,034 95.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENNEX LAB. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GENNEX LABORATORIES vs ADVANCED ENZYME TECHNOLOGIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GENNEX LABORATORIES vs ADVANCED ENZYME TECHNOLOGIES Share Price Performance

Period GENNEX LABORATORIES ADVANCED ENZYME TECHNOLOGIES S&P BSE HEALTHCARE
1-Day 1.35% -1.96% 1.18%
1-Month -13.90% -9.39% -0.75%
1-Year 189.91% 51.81% 61.82%
3-Year CAGR 62.78% -0.39% 18.16%
5-Year CAGR 40.09% 15.53% 19.79%

* Compound Annual Growth Rate

Here are more details on the GENNEX LABORATORIES share price and the ADVANCED ENZYME TECHNOLOGIES share price.

Moving on to shareholding structures...

The promoters of GENNEX LABORATORIES hold a 23.6% stake in the company. In case of ADVANCED ENZYME TECHNOLOGIES the stake stands at 43.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GENNEX LABORATORIES and the shareholding pattern of ADVANCED ENZYME TECHNOLOGIES.

Finally, a word on dividends...

In the most recent financial year, GENNEX LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

ADVANCED ENZYME TECHNOLOGIES paid Rs 5.0, and its dividend payout ratio stood at 53.8%.

You may visit here to review the dividend history of GENNEX LABORATORIES, and the dividend history of ADVANCED ENZYME TECHNOLOGIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.